CDT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Conduit Pharmaceuticals Inc (CDT).


$335.92M Market Cap.

As of 04/16/2024 5:00 PM ET (MRY) • Disclaimer

CDT Market Cap. (MRY)


CDT Shares Outstanding (MRY)


CDT Assets (MRY)


Total Assets

$7.22M

Total Liabilities

$7.68M

Total Investments

$0

CDT Income (MRY)


Revenue

$0

Net Income

-$535.00K

Operating Expense

$5.26M

CDT Cash Flow (MRY)


CF Operations

-$7.72M

CF Investing

$725.00K

CF Financing

$10.93M

CDT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

-

0%

-

CDT Balance Sheet (MRY)


Metric

2023

2022

2021

Total Assets

$7,224,000 (144380.00%)

$5,000 (0%)

$0

Assets Current

$5,733,000 (0%)

$0 (0%)

$104,163

Assets Non-Current

$1,491,000 (29720.00%)

$5,000 (-95.41%)

$108,962

Goodwill & Intangible Assets

$0 (0%)

$5,000 (0%)

$0

Shareholders Equity

-$457,000 (95.47%)

-$10,089,000 (-69.79%)

-$5,942,000

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0

Cash & Equivalents

$4,228,000 (0%)

$0 (0%)

$0

Accumulated Other Comprehensive Income

$411,000 (-39.11%)

$675,000 (1138.46%)

-$65,000

Deferred Revenue

$0 (0%)

$0 (0%)

$2,958,000

Total Investments

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$215,000 (0%)

$0 (0%)

$0

Accumulated Retained Earnings (Deficit)

-$11,299,000 (-4.91%)

-$10,770,000 (-83.26%)

-$5,877,000

Tax Assets

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0

Total Debt

$985,000 (-83.83%)

$6,093,000 (713.48%)

$749,000

Debt Current

$985,000 (0%)

$0 (0%)

$0

Debt Non-Current

$0 (0%)

$6,093,000 (713.48%)

$749,000

Total Liabilities

$7,681,000 (-23.91%)

$10,094,000 (69.88%)

$5,942,000

Liabilities Current

$1,801,000 (-30.30%)

$2,584,000 (15.62%)

$2,235,000

Liabilities Non-Current

$5,880,000 (-21.70%)

$7,510,000 (102.59%)

$3,707,000

CDT Income Statement (MRY)


Metric

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$5,172,000 (69.63%)

$3,049,000 (5.50%)

$2,890,000

Research & Development Expense

$90,000 (143.24%)

$37,000 (32.14%)

$28,000

Operating Expenses

$5,262,000 (66.52%)

$3,160,000 (-0.41%)

$3,173,000

Interest Expense

$211,000 (0%)

$0 (0%)

$0

Income Tax Expense

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0

Net Income

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Weighted Average Shares

$66,973,906 (-96.65%)

$2,000,000,000 (100.00%)

$1,000,000,000

Weighted Average Shares Diluted

$67,893,881 (-96.61%)

$2,000,000,000 (100.00%)

$1,000,000,000

Earning Before Interest & Taxes (EBIT)

-$324,000 (93.37%)

-$4,887,000 (-33.63%)

-$3,657,000

Gross Profit

$0 (0%)

$0 (0%)

$0

Operating Income

-$5,262,000 (-66.52%)

-$3,160,000 (0.41%)

-$3,173,000

CDT Cash Flow Statement (MRY)


Metric

2023

2022

2021

Net Cash Flow from Investing

$725,000 (496.17%)

-$183,000 (0%)

$0

Net Cash Flow from Financing

$10,929,000 (346.45%)

$2,448,000 (28.98%)

$1,898,000

Net Cash Flow from Operations

-$7,725,000 (-240.91%)

-$2,266,000 (-5.35%)

-$2,151,000

Net Cash Flow / Change in Cash & Cash Equivalents

$4,228,000 (0%)

$0 (0%)

-$252,000

Net Cash Flow - Business Acquisitions and Disposals

-$357,000 (-7.85%)

-$331,000 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$1,082,000 (631.08%)

$148,000 (0%)

$0

Capital Expenditure

$0 (0%)

$0 (0%)

$0

Issuance (Repayment) of Debt Securities

$2,286,000 (106.50%)

$1,107,000 (60.90%)

$688,000

Issuance (Purchase) of Equity Shares

$8,643,000 (0%)

$0 (0%)

$0

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$299,000 (29800.00%)

$1,000 (0.00%)

$1,000

Share Based Compensation

$199,000 (0%)

$0 (0%)

$0

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0

CDT Financial Metrics (MRY)


Metric

2023

2022

2021

Gross Margin

-

-

-

Profit Margin

-

-

-

EBITDA Margin

-

-

-

Return on Average Equity (ROAE)

7.30% (-92.47%)

97.00%

-

Return on Average Assets (ROAA)

-11.10% (-131.25%)

-4.80%

-

Return on Sales (ROS)

-

-

-

Return on Invested Capital (ROIC)

-33.60% (-600.00%)

-4.80%

-

Dividend Yield

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-455 (-11374900.00%)

-0

-

Price to Sales Ratio (P/S)

-

-

-

Price to Book Ratio (P/B)

-735.06 (-4085.78%)

-17.56

-

Debt to Equity Ratio (D/E)

-16.81 (-1580.70%)

-1 (0.00%)

-1

Earnings Per Share (EPS)

-0.01 (100.00%)

-2,444 (33.17%)

-3,657

Sales Per Share (SPS)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-0.12 (-11400.00%)

-0 (50.00%)

-0

Book Value Per Share (BVPS)

-0.01 (-40.00%)

-0.01 (16.67%)

-0.01

Tangible Assets Book Value Per Share (TABVPS)

0.11 (0%)

0 (0%)

0

Enterprise Value Over EBIT (EV/EBIT)

-1,021 (-2736.11%)

-36

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1,021.38 (-2728.91%)

-36.1

-

Asset Turnover

0 (0%)

0

-

Current Ratio

3.18 (0%)

0 (0%)

0.05

Dividends

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$7,725,000 (-240.91%)

-$2,266,000 (-5.35%)

-$2,151,000

Enterprise Value (EV)

$330,926,389 (87.55%)

$176,445,740

-

Earnings Before Tax (EBT)

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$324,000 (93.37%)

-$4,887,000 (-33.63%)

-$3,657,000

Invested Capital

$2,180,000 (-37.87%)

$3,509,000 (336.14%)

-$1,486,000

Working Capital

$3,932,000 (252.17%)

-$2,584,000 (-21.27%)

-$2,130,837

Tangible Asset Value

$7,224,000 (0%)

$0 (0%)

$0

Market Capitalization

$335,924,389 (89.60%)

$177,173,812

-

Average Equity

-$7,365,750 (-46.15%)

-$5,039,715

-

Average Assets

$4,815,000 (-95.30%)

$102,463,244

-

Invested Capital Average

$964,000 (-99.06%)

$102,573,371

-

Shares

73,829,536 (327.12%)

17,285,250

-